ACHC

Florida Cancer Specialists & Research Institute Participates in Global Gathering to Share Advances in Oncology Pharmacy Services

Retrieved on: 
Friday, May 6, 2022
ASCO, American Society of Clinical Oncology, Stanford University, Duke, Board, Health, GLOBE, NABP, National Association, Physician, Patient, Immunotherapy, U.S. News & World Report, Monroe Dunaway Anderson, Cancer, Memorial Sloan Kettering Cancer Center, Pharmacist, URAC, MD, Harvard University, Pharmacy, Accreditation Commission for Health Care, Disease management, Society, Specialty pharmacy, News, Pharmacy technician, University of Florida Cancer and Genetics Research Complex, Research, Doctor of Pharmacy, ACHC, FCS, Medicine, Hospital, Pharmaceutical industry, Bachelor of Pharmacy

Fort Myers, Fla., May 06, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute(FCS ) clinicians and leaders shared the latest advances in oncology pharmacy operations and dispensing practices at theNational Community Oncology Dispensing Association (NCODA) 2022 Spring Forum held last month in Atlanta.

Key Points: 
  • Fort Myers, Fla., May 06, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute(FCS ) clinicians and leaders shared the latest advances in oncology pharmacy operations and dispensing practices at theNational Community Oncology Dispensing Association (NCODA) 2022 Spring Forum held last month in Atlanta.
  • The multi-day gathering of global oncology care professionals delved into new opportunities to enhance the value of pharmacy services within medically integrated oncology practices.
  • Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida.
  • Over the past 5 years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.

PANTHERx Rare Celebrates Fifth Patient Choice Award Win

Retrieved on: 
Wednesday, May 4, 2022
NPS, Tenacity, Senior, Culture, Empathy, Patient, NABP, Medicine, National Association, ZHI, Degenerative disease, Perception, FDA, Incidence, Diabetes, URAC, Accreditation Commission for Health Care, Disease, NASP, Science, Specialty pharmacy, ACHC, Consultant, Multimedia, Philosophy, Pharmaceutical industry, Pharmacy

PITTSBURGH, May 4, 2022 /PRNewswire/ -- For a fifth time, PANTHERx Rare has been recognized as the winner of the annual, Specialty Pharmacy Patient Choice Award.

Key Points: 
  • PITTSBURGH, May 4, 2022 /PRNewswire/ -- For a fifth time, PANTHERx Rare has been recognized as the winner of the annual, Specialty Pharmacy Patient Choice Award.
  • Since 2016, the Managed Markets Insights & Technology Zitter Health Insight's (MMIT ZHI) Patient Choice Award has honored the winning specialty pharmacy's exemplary commitment to patients.
  • For a fifth time, the MMIT ZHI Patient Choice Award has validated this philosophy that those of us at PANTHERx always knew to be true," said PANTHERx President, Rob Snyder.
  • PANTHERx is now a five-time winner of the prestigious MMIT Patient Choice Award, including the 2022 honor.

The AscellaHealth Family of Companies Expands Executive Team Leadership for Ongoing Support of Strategic Business Initiatives and Accelerated Growth

Retrieved on: 
Tuesday, May 3, 2022
Health, Hospitals, Other Health, Managed Care, General Health, Clinical Trials, Pharmaceutical, Board, Company, Tiffany, Patient, Partnership, Degenerative disease, URAC, Overalls, Industry, Business development, Compliance, List of life sciences, Leadership, Advertising, Electronic Healthcare Network Accreditation Commission, Board of directors, Quality of life, Marketing, Specialty pharmacy, CEO, ACHC, Growth, Awareness, Multimedia, Hospital, Management

View the full release here: https://www.businesswire.com/news/home/20220503005483/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220503005483/en/
    AscellaHealth Family of Companies Leadership Announcement (Photo: Business Wire)
    Our outstanding executive team continues to demonstrate exceptional capabilities to develop, promote and successfully drive the AscellaHealth Family of Companies innovative Specialty Pharmacy programs and services, says Dea Belazi, president and CEO, AscellaHealth.
  • Tiffany Ellen Burt has been hired as president and chief operating officer of Optime Care.
  • Tiffany comes to Optime Care with over two decades of healthcare and pharmaceutical experience, including deep leadership skills contributing to overall business growth.
  • Our experience with small patient populations, coupled with our strategic partnership with AscellaHealth , enhances our services and ability to serve the specialty pharmacy market.

Massive Bio and Amber Specialty Pharmacy Announce Nationwide Partnership to Revolutionize Digitally Enabled Oncology Clinical Trial Recruitment through AI Technology Platform

Retrieved on: 
Tuesday, May 3, 2022
Technology, Medical Devices, Medical Supplies, Other Technology, Clinical Trials, Software, Hardware, Pharmaceutical, Health, Oncology, Drug development, NASA, Ecosystem, Twitter, SBIR, National Association, Time, COE, Oncology, Patient, Partnership, Caregiver, National Cancer Institute, Clinical trial, URAC, Risk, Person, National, Cancer, Deep learning, Environment, Industry, Artificial intelligence, CRO, Pharmacy, Electronic Healthcare Network Accreditation Commission, Precision medicine, Contract research organization, LinkedIn, Movement, Physical Sciences-Oncology Centers, IOS, Cros, Education, Specialty pharmacy, Android, Goal, Technology, Research, ACHC, Entrepreneurship, NCI, Digital, Medical imaging, Medical device, Pharmaceutical industry, Facebook

Amber Specialty Pharmacy is dedicated to meeting the clinical, emotional, and financial needs of cancer patients and their caregivers.

Key Points: 
  • Amber Specialty Pharmacy is dedicated to meeting the clinical, emotional, and financial needs of cancer patients and their caregivers.
  • Massive Bios AI technology platform and expertise in cancer clinical trials are fully aligned with these goals, resulting in improved health outcomes and reduced costs for the industry, Williams added.
  • Amber Specialty Pharmacy has built an exceptional reputation by providing personalized support and quality clinical care to patients and families.
  • Amber Specialty Pharmacy was named the 2020 Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy.

DirectRx Pharmacy Awarded Going Pro Talent Fund Grant to Invest in Employee Training and Education

Retrieved on: 
Thursday, April 28, 2022
ACHC, CQI, URAC, Pharmacy, Patient, GLOBE, Technology, Partnership, Labour, Michigan Department of Labor and Economic Opportunity, Compliance, Investment, Accreditation, Hospital

DirectRx is one of 125 Oakland County employers that were awarded Going Pro Talent Fund grants.

Key Points: 
  • DirectRx is one of 125 Oakland County employers that were awarded Going Pro Talent Fund grants.
  • In total, employers will share $3.4 million in Going Pro Talent Fund grants awarded by the Michigan Department of Labor and Economic Opportunity.
  • The Going Pro Talent Grant will serve to maintain this continuous improvement and commitment to excellence.
  • DirectRx, an independent specialty pharmacy with dual accreditation from both ACHC and URAC, provides patients with unparalleled, personalized pharmaceutical care.

AscellaHealth Launches Family of Companies, Expands Specialty Pharmacy Services and Capabilities to Serve Patients, Payers, Life Sciences and Providers

Retrieved on: 
Wednesday, April 27, 2022
General Health, Other Health, Health, Pharmaceutical, Managed Care, Family, CEO, Marketing, Degenerative disease, ACHC, Diagnosis, Compliance, Patient, URAC, Electronic Healthcare Network Accreditation Commission, SP, List of life sciences, Solution, Disorder, Industry, Quality of life, Partnership, Company, HUB, Fine chemical, Pharmaceutical industry, Healthcare

AscellaHealth continues to grow its business portfolio globally and ascend its market positioning as a premier partner in SP and healthcare services that puts patients at the center of care.

Key Points: 
  • AscellaHealth continues to grow its business portfolio globally and ascend its market positioning as a premier partner in SP and healthcare services that puts patients at the center of care.
  • AscellaHealths consultative, patient-first approach is built upon proprietary technology processes designed to support pharmaceutical manufacturers in product launches and drug management programs, continues Belazi.
  • AscellaHealth is a global Healthcare & Specialty Pharmacy solutions organization serving patients, payers, life sciences and providers, offering a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and medical management services.
  • Our experience with small patient populations, coupled with our strategic partnership with AscellaHealth , enhances our services and ability to serve the specialty pharmacy market.

Soleo Health Earns Specialty Pharmacy Reaccreditation From URAC

Retrieved on: 
Wednesday, April 20, 2022
Clinical Trials, Insurance, Cardiology, Biotechnology, Other Science, Health, Research, Professional Services, Science, Software, Nursing, Medical Supplies, Other Health, FDA, Practice Management, Diabetes, Radiology, Managed Care, Pharmaceutical, General Health, Technology, Oncology, Medical Devices, Infectious Diseases, Hospitals, Joint Commission, Pharmaceutical Services Negotiating Committee, Twitter, Risk management, ACHC, Health, Caregiver, Compliance, Distinction, Patient satisfaction, Organization, Education, Patient, Patient safety, LinkedIn, Pharmacy, Company, Pharmacist, Solution, Conditional sentence, URAC, Facebook, Accreditation, Hospital, Health insurance

Soleo Health , an innovative leader and national provider of complex specialty pharmacy services, announced today it earned Specialty Pharmacy Accreditation from URAC .

Key Points: 
  • Soleo Health , an innovative leader and national provider of complex specialty pharmacy services, announced today it earned Specialty Pharmacy Accreditation from URAC .
  • Soleo Health earned reaccreditation with a score of 100 percent for its pharmacy locations in Chicago, Philadelphia, Phoenix and Columbus, Ohio, in the latest URAC survey, which occurs every three years.
  • Soleo Health received reaccreditation for these locations after exhibiting its commitment to delivering quality, patient-centric care through exceptional therapy management programs.
  • Soleo Health is an innovative national provider of complex specialty pharmacy services administered in the home or at alternate sites of care.

DirectRx Pharmacy Launches DirectFlow Technology to Streamline Provider Communications

Retrieved on: 
Monday, April 4, 2022
CQI, Compliance, ACHC, Doctor of Pharmacy, Communication, Technology, URAC, Investment, Pharmacy, GLOBE, Kastriot Berishaj, Physician, Accreditation, Efficiency, Insurance, Patient, Hospital, Medicine

TROY, Mich., April 04, 2022 (GLOBE NEWSWIRE) -- Independent specialty pharmacy DirectRx announced today the launch and implementation of DirectFlow technology, designed to streamline the process of communicating patient information between physicians offices and the DirectRx pharmacy team.

Key Points: 
  • TROY, Mich., April 04, 2022 (GLOBE NEWSWIRE) -- Independent specialty pharmacy DirectRx announced today the launch and implementation of DirectFlow technology, designed to streamline the process of communicating patient information between physicians offices and the DirectRx pharmacy team.
  • The external validation of excellence in Specialty Pharmacy Management ensures that the pharmacy provides Continuous Quality Improvement (CQI) oriented processes that improve operations and enhance compliance.
  • DirectRx, an independent specialty pharmacy with dual accreditation from both ACHC and URAC, provides patients with unparalleled, personalized pharmaceutical care.
  • DirectRx is owned and operated by certified doctors of pharmacy The company operates in 49 states.

Soleo Health Urges US Department of Health & Human Services to Provide Patients Access to Monoclonal Antibodies for Treatment of Alzheimer’s Disease

Retrieved on: 
Wednesday, March 16, 2022
White House, Federal Government, Other Health, Public Policy, Government, Radiology, Other Science, Software, Pharmaceutical, Research, Oncology, Medical Devices, Healthcare Reform, Infectious Diseases, Hospitals, Technology, Clinical Trials, Cardiology, Science, Biotechnology, Practice Management, Insurance, Nursing, Managed Care, Medical Supplies, General Health, Health, Diabetes, Professional Services, National coverage determination, Association, Center, Twitter, Joint Commission, Quality of life, Solution, Ageing, Dementia, Facebook, Patient, Therapy, FDA, Pharmacy, National Institute on Aging, COVID-19, Food and Drug Administration, Amyloid, Health, NCD, Centers for Medicare & Medicaid Services, National Institute, Pharmacist, Company, Population, URAC, Center for Medicare and Medicaid Innovation, Death, Human services, Distinction, CMS, LinkedIn, ACHC, Hospital, Pharmaceutical industry

Soleo Health , an innovative leader and national provider of complex specialty pharmacy services, announced today it is urging Centers for Medicare & Medicaid Services (CMS), US Department of Health & Human Services to allow patient access to monoclonal antibodies directed against Amyloid for the treatment of Alzheimers Disease.

Key Points: 
  • Soleo Health , an innovative leader and national provider of complex specialty pharmacy services, announced today it is urging Centers for Medicare & Medicaid Services (CMS), US Department of Health & Human Services to allow patient access to monoclonal antibodies directed against Amyloid for the treatment of Alzheimers Disease.
  • The proposed National Coverage Determination (NCD) by CMS will unnecessarily limit patient access to important treatment advancements for this devastating disease.
  • Soleo Health also expressed its opposition to the proposed NCDs requirement that designates CMS-approved clinical trials be limited to hospital-based outpatient facilities.
  • Patient access to innovative therapy treatments is critical to supporting our aging population, including the recent FDA-approved monoclonal antibody treatment for Alzheimers patients.

Soleo Health’s Atlanta Pharmacy Relocates to Meet Growing Patient Demand

Retrieved on: 
Monday, March 7, 2022
Professional Services, Other Science, Research, Science, Stem Cells, Nursing, Practice Management, Medical Supplies, Other Health, FDA, Managed Care, Diabetes, Radiology, General Health, Pharmaceutical, Oncology, Medical Devices, Infectious Diseases, Hospitals, Genetics, Software, Fitness & Nutrition, Clinical Trials, Cardiology, Biotechnology, AIDS, Technology, Health, Surgery, Insurance, BSN, RN, URAC, Patient, Cummings, Twitter, TED, LinkedIn, Haemophilia, Solution, ACHC, Suite, Company, GMG, Pharmacy, Graves' ophthalmopathy, Joint Commission, ICU, Pharmacist, Foot, Parenteral nutrition, Food and Drug Administration, Facebook, Muscular dystrophy, Classification, Health, ALS, Amyotrophic lateral sclerosis, Distinction, Hospital, Medicine

Soleo Health , an innovative leader and national provider of complex specialty pharmacy services, announced today the relocation of its Atlanta pharmacy .

Key Points: 
  • Soleo Health , an innovative leader and national provider of complex specialty pharmacy services, announced today the relocation of its Atlanta pharmacy .
  • Soleo Health also offers five private ambulatory infusion suites for patients receiving complex biologic and infusion therapies.,
    From the new pharmacy location, Soleo Health Atlanta manages the delivery of a broad range of specialty pharmacy services and infusion therapies.
  • Among the therapies and complex specialty pharmaceuticals Soleo Health Atlanta administers are, to name a few, antibiotic treatment, parenteral nutrition and inotropic therapy for acute patient care needs.
  • Soleo Healths interdisciplinary team comprises highly experienced pharmacists, registered nurses, reimbursement specialists and patient care ambassadors.